IRIS
STEFANINI, Giulio Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.671
AS - Asia 6.550
EU - Europa 1.846
SA - Sud America 1.526
AF - Africa 292
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 6
Totale 18.908
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.484
SG - Singapore 4.118
BR - Brasile 1.280
CN - Cina 1.037
VN - Vietnam 633
FI - Finlandia 375
IE - Irlanda 277
DE - Germania 214
IT - Italia 208
NG - Nigeria 177
IN - India 162
HK - Hong Kong 150
FR - Francia 142
GB - Regno Unito 129
SE - Svezia 119
NL - Olanda 101
AR - Argentina 97
CA - Canada 78
BD - Bangladesh 65
MX - Messico 61
RU - Federazione Russa 55
TR - Turchia 52
IQ - Iraq 50
EC - Ecuador 39
ID - Indonesia 39
PL - Polonia 37
ES - Italia 33
JP - Giappone 30
UA - Ucraina 28
VE - Venezuela 28
ZA - Sudafrica 28
MA - Marocco 23
SA - Arabia Saudita 22
BE - Belgio 21
PK - Pakistan 20
CO - Colombia 19
PE - Perù 18
IL - Israele 17
PH - Filippine 17
CL - Cile 16
PY - Paraguay 16
UZ - Uzbekistan 15
DZ - Algeria 14
AZ - Azerbaigian 13
GR - Grecia 13
MY - Malesia 13
KE - Kenya 12
AE - Emirati Arabi Uniti 11
AU - Australia 11
JM - Giamaica 11
JO - Giordania 11
LT - Lituania 11
AT - Austria 10
PT - Portogallo 10
CZ - Repubblica Ceca 9
EG - Egitto 9
UY - Uruguay 9
CR - Costa Rica 8
NP - Nepal 8
RO - Romania 8
KZ - Kazakistan 7
TH - Thailandia 7
TW - Taiwan 7
CH - Svizzera 6
OM - Oman 6
PA - Panama 6
SN - Senegal 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
KW - Kuwait 5
LB - Libano 5
TN - Tunisia 5
AL - Albania 4
BO - Bolivia 4
GT - Guatemala 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
CU - Cuba 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
IR - Iran 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NO - Norvegia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
BS - Bahamas 2
CI - Costa d'Avorio 2
GE - Georgia 2
KH - Cambogia 2
KR - Corea 2
LU - Lussemburgo 2
Totale 18.874
Salva come PNG Salva come JPEG
Città #
Singapore 1.906
Chandler 980
Wilmington 956
Ashburn 841
The Dalles 608
San Jose 596
Shanghai 524
Dallas 504
San Mateo 417
Helsinki 373
Boardman 272
Dublin 271
Beijing 253
Ho Chi Minh City 229
Ann Arbor 228
New York 228
Lawrence 181
Princeton 181
Benin City 177
Hanoi 159
Leawood 147
Hong Kong 135
São Paulo 117
Los Angeles 99
Woodbridge 98
Paris 95
Fairfield 90
Amsterdam 86
Pune 57
Milan 53
Seattle 45
Santa Clara 42
London 40
Munich 36
Falkenstein 34
Warsaw 34
Phoenix 32
Brasília 29
Orem 29
Rio de Janeiro 29
Belo Horizonte 27
Da Nang 27
Council Bluffs 26
Chennai 25
Curitiba 25
Montreal 25
Kocaeli 24
Tokyo 23
Brooklyn 22
Chicago 21
Brussels 20
Haiphong 20
Norwalk 20
San Diego 20
Stockholm 20
Baghdad 19
Mexico City 19
Toronto 19
Campinas 16
Cologno Monzese 16
Dhaka 16
Reston 16
Ribeirão Preto 16
San Francisco 16
Frankfurt am Main 15
Guarulhos 15
Assago 14
Quito 14
Guayaquil 13
Atlanta 12
Boston 12
Fortaleza 12
Johannesburg 12
Manchester 12
Moscow 12
Naples 12
Porto Alegre 12
Redmond 12
Baku 11
Denver 11
Hải Dương 11
Nairobi 11
New Delhi 11
Tashkent 11
Abbiategrasso 10
Buenos Aires 10
Kuala Lumpur 10
Redwood City 10
Amman 9
Caxias do Sul 9
Goiânia 9
Guangzhou 9
Houston 9
Kingston 9
Lima 9
Asunción 8
Athens 8
Columbus 8
Delhi 8
Des Moines 8
Totale 12.097
Salva come PNG Salva come JPEG
Nome #
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 122
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 120
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention. 117
2014 ESC/EACTS Guidelines on myocardial revascularization 112
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 110
2014 ESC/EACTS Guidelines on myocardial revascularization. 108
2018 ESC/EACTS Guidelines on myocardial revascularization 108
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 108
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 107
CAD in TAVI patients: relevance of disease complexity 105
4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New Generation Drug-Eluting Stents in the RESOLUTE All Comers Randomized Trial. 105
2014 ESC/EACTS Guidelines on myocardial revascularization 105
Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. 105
How should I treat a DES restenosis in a graft anastomosis with challenging access and multiple previous coronary interventions? 104
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. 102
2018 ESC/EACTS Guidelines on myocardial revascularization. 102
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 99
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 98
What constitutes sufficient clinical evidence for stents? SpotLITE on the evaluation of novel coronary devices. 97
2018 ESC/EACTS Guidelines on myocardial revascularization 97
A new device for vascular embolization: report on case of two pulmonary arteriovenous fistulas embolization using the amplatzer vascular plug 97
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients 95
Does clinical data quality affect fluid-structure interaction simulations of patient-specific stenotic aortic valve models? 94
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. 94
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 93
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 93
[Towards a standardized and minimalist future in interventional cardiology] 92
[Advances in the treatment of complex atherosclerotic disease: cracking the calcium and beyond] 92
An update on drug-eluting stents versus bare-metal stents in PCI treatment: are there any remaining indications for BMS use? 91
On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid–Structure Interaction Approach 91
Clinical outcomes of bioresorbable versus durable polymer-coated everolimus-eluting stents in real-world complex patients. 90
Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation 89
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. 89
Efficacy and Safety of Calcium Channel Blocker/Diuretics Combination Therapy in Hypertensive Patients: A Meta-Analysis. 88
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 88
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 87
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 87
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom (TM) drug-coated stent vs. the Gazelle (TM) bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy 86
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis 85
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study 85
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 85
Another reason to endorse and spread guidelines 85
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. 84
Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis 84
Aspiration Thrombectomy for Treatment of ST-segment Elevation Myocardial Infarction: a Meta-analysis of 26 Randomized Trials in 11 943 Patients 84
Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review 84
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 83
Coronary stents: novel developments 83
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study 83
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 83
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 82
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 82
The synergy stent in high-bleeding risk patients: why design matters 81
Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality 81
Coronary Artery Disease Severity and Aortic Stenosis: Clinical Outcomes According to SYNTAX-Score in Patients Undergoing Transcatheter Aortic Valve Implantation 81
New approach to direct stenting using a novel 'All-In-One' coronary stent system via 5 french diagnostic catheters: A pilot study 81
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 81
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 79
Surgical or percutaneous revascularization for isolated left anterior descending stenoses: are we in the same boat? 78
What's new in the 2018 ESC/EACTS guidelines on myocardial revascularization? 78
Can Coronary Computed Tomography Angiography Replace Invasive Angiography? Coronary Computed Tomography Angiography Cannot Replace Invasive Angiography 78
Characterization of Myocardial Injury in Patients With COVID-19 78
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 77
[SICI-GISE/SICOA Consensus document: Clinical follow-up of patients after acute coronary syndrome or percutaneous coronary intervention] 76
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials. 76
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. 76
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 76
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 76
Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention: A Meta-Analysis of Randomized Trials 75
Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes 75
Safety and Efficacy of Resolute Zotarolimus-Eluting Stents Compared With Everolimus-Eluting Stents A Meta-Analysis 75
State of the art: coronary artery stents - past, present and future. 75
Management of ST-elevation myocardial infarction according to European and American guidelines. 74
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis 74
Stent performance: never too late to sort it out. 74
[Cardiac biomarkers in patients with COVID-19: pragmatic tools in hard times] 73
Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry 73
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study. 73
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 73
Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques. 73
The Valsalva maneuver in the diagnosis of patent foramen ovale. 72
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. 72
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. 72
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial 72
Predictors of Adverse Events Among Patient Undergoing Primary Percutaneous Coronary Intervention - Insights From a Pooled Analysis of the COMFORTABLE-AMI and EXAMINATION trials 72
Severe aortic stenosis and coronary artery disease. 72
P2Y12 vs. aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and Meta-analysis 71
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 71
Myocardial ischemia and coronary disease in heart failure. 70
Myocardial revascularization appropriateness in Italy: Measuring the unmeasured 70
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention Results of a Nonrandomized Observational Study 70
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. 70
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration 70
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 70
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 69
Are the culprit lesions severely stenotic? 69
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. 69
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents A Patient-Level Pooled Analysis of Randomized Controlled Trials 69
Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 69
Direct oral anticoagulants versus Vitamin K antagonists in the treatment of left ventricular thrombosis: a systematic review and meta-analysis 68
Totale 8.486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.384
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021428 0 0 0 0 0 0 0 0 0 240 2 186
2021/2022902 24 9 16 245 6 2 21 148 73 68 246 44
2022/20232.885 421 110 236 313 315 206 13 213 514 287 197 60
2023/20242.132 222 151 406 128 105 275 153 128 20 49 196 299
2024/20253.368 45 32 43 32 60 351 281 330 478 837 416 463
2025/20268.185 1.377 683 500 871 313 460 2.541 473 465 502 0 0
Totale 19.288